• Mutation; HGNC; HGNC:7427; MT-CYB; Simple; p.Asp171Asn (m.15257G>A); ClinVar=VCV000009674; Zygosity=Heteroplasmic (from child cell line KUCFRi003-A).
  

PubMed=2376596; DOI=10.1016/S0021-9258(19)38301-2
Huh T.-L., Casazza J.P., Huh J.-W., Chi Y.-T., Song B.J.
Characterization of two cDNA clones for pyruvate dehydrogenase E1 beta subunit and its regulation in tricarboxylic acid cycle-deficient fibroblast.
J. Biol. Chem. 265:13320-13326(1990)

CLPUB00447
Mulivor R.A., Suchy S.F.
1992/1993 catalog of cell lines. NIGMS human genetic mutant cell repository. 16th edition. October 1992.
(In misc. document) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda; USA (1992)

PubMed=30471880; DOI=10.1016/j.kint.2018.08.038; PMCID=PMC6389356
Johnson S.C., Martinez F., Bitto A., Gonzalez B., Tazaerslan C., Cohen C., Delaval L., Timsit J., Knebelmann B., Terzi F., Mahal T., Zhu Y.-Z., Morgan P.G., Sedensky M.M., Kaeberlein M., Legendre C., Suh Y., Canaud G.
mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.
Kidney Int. 95:455-466(2019)

PubMed=34091428; DOI=10.1016/j.scr.2021.102392
Son D., Zheng J., Kim I.Y., You S.
Self-replicative mRNA-mediated generation of induced pluripotent stem cell line from a 1-year-old Leigh syndrome patient with mitochondrial DNA cytochrome b mutation.
Stem Cell Res. 54:102392-102392(2021)